UAE In Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The UAE In Vitro Diagnostics Market is segmented by Test Type (Clinical Chemistry, Immunodiagnostics, Molecular Diagnostics, Hematology, and Other Test Types), Product (Instrument, Reagent, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications), and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users).

Market Snapshot

Picture 1
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The growth of the UAE in vitro diagnostics market can be attributed to factors, such as high prevalence of chronic and infectious diseases. Chronic diseases, such as cancer, diabetes, and various respiratory diseases, are posing as a global challenge.

According to the International Diabetes Federation, currently, 55 million people are suffering from diabetes in the MENA region. The current market is also growing due to the use of advanced technologies in the market studied. 

There has been a paradigm shift from traditional diagnostics to a new generation diagnostics that work at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS). Hence, these factors are expected to drive market growth.

Scope of the Report

  • In vitro diagnostics involve medical devices and consumables that are utilized to perform in vitro tests on various biological samples. They are used for the diagnosis of various medical conditions, such as chronic diseases. 
  • The in vitro diagnostics market is segmented by test type (clinical chemistry, immunodiagnostics, molecular diagnostics, hematology, and other test types), product (instrument, reagent, and other products), usability (disposable IVD devices and reusable IVD devices), application (infectious disease, diabetes, cancer/oncology, cardiology, autoimmune disease, nephrology, and other applications), and end user (diagnostic laboratories, hospitals and clinics, and other end users).
By Test Type
Clinical Chemistry
Molecular Diagnostics
Other Test Types
By Product
Other Products
By Usablity
Disposable IVD Devices
Reusable IVD Devices
By Application
Infectious Disease
Autoimmune Disease
Other Applications
By End User
Diagnostic Laboratories
Hospitals and Clinics
Other End Users

Report scope can be customized per your requirements. Click here.

Key Market Trends

Reagents Segment Holds the Largest Market Share

  • Reagents capture the largest market share and are expected to exhibit the fastest growth rate over the forecast period, owing to repeat purchase and increasing demand. The reagent segment of the market studied includes chemical, biological, or immunological components, solutions, and preparations, intended by the manufacturer to be used during the in vitro diagnostic process. 
  • Given the high cost of many diagnostic platforms, it is common for manufacturers to lease equipment, instead of selling technology outright to end users. In these arrangements, the lease is tied to contracts to purchase associated reagents or assay kits for the equipment, over the life of the contract.
  • Many diagnostic companies have in excess of 75% of sales from consumables, such as assays and reagents, and such agreements guarantee the generation of cyclic revenues associated with the sale of reagents and other consumables. Reagent usage for IVD kits often carries high costs, hence, the availability of immunodiagnostic services in developing countries is often limited by the high cost of imported kits. 
  • Many developing countries have established local immunoassay reagent programs to manufacture low-cost, high-quality immunoassay reagents. Kits from these projects are now beginning to become available and are likely to fuel the market expansion.
UAE IVD Market Trend.png

Competitive Landscape

The major market players in the UAE in vitro diagnostics market are bioMérieux, QIAGEN, Abbott Laboratories, F Hoffmann-La Roche Ltd, and Siemens Healthineers AG, among others. The competition among manufacturers is increasing, with the increasing number of companies. Small manufacturers represent an unorganized market, due to the lower prices of their products.

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 High Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Use of Point-of-care (POC) Diagnostics

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 Stringent Regulations

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Test Type

      1. 5.1.1 Clinical Chemistry

      2. 5.1.2 Immunodiagnostics

      3. 5.1.3 Molecular Diagnostics

      4. 5.1.4 Hematology

      5. 5.1.5 Other Test Types

    2. 5.2 By Product

      1. 5.2.1 Instrument

      2. 5.2.2 Reagent

      3. 5.2.3 Other Products

    3. 5.3 By Usablity

      1. 5.3.1 Disposable IVD Devices

      2. 5.3.2 Reusable IVD Devices

    4. 5.4 By Application

      1. 5.4.1 Infectious Disease

      2. 5.4.2 Diabetes

      3. 5.4.3 Cancer/Oncology

      4. 5.4.4 Cardiology

      5. 5.4.5 Autoimmune Disease

      6. 5.4.6 Nephrology

      7. 5.4.7 Other Applications

    5. 5.5 By End User

      1. 5.5.1 Diagnostic Laboratories

      2. 5.5.2 Hospitals and Clinics

      3. 5.5.3 Other End Users


    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Becton, Dickinson and Company

      3. 6.1.3 bioMérieux

      4. 6.1.4 Bio-Rad Laboratories Inc.

      5. 6.1.5 Danaher Corporation

      6. 6.1.6 QIAGEN

      7. 6.1.7 F Hoffmann-La Roche Ltd

      8. 6.1.8 Siemens Healthineers AG

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 Thermo Fisher Scientific

    2. *List Not Exhaustive

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The UAE In Vitro Diagnostics Market market is studied from 2018 - 2026.

The UAE In Vitro Diagnostics Market is growing at a CAGR of 5% over the next 5 years.

bioMérieux, Abbott Laboratories, F Hoffmann-La Roche Ltd, Siemens Healthineers AG, QIAGEN are the major companies operating in UAE In Vitro Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!